882 related articles for article (PubMed ID: 28391159)
1. Inhibitory effects of quercetin on the progression of liver fibrosis through the regulation of NF-кB/IкBα, p38 MAPK, and Bcl-2/Bax signaling.
Wang R; Zhang H; Wang Y; Song F; Yuan Y
Int Immunopharmacol; 2017 Jun; 47():126-133. PubMed ID: 28391159
[TBL] [Abstract][Full Text] [Related]
2. Ginkgo biloba extract mitigates liver fibrosis and apoptosis by regulating p38 MAPK, NF-κB/IκBα, and Bcl-2/Bax signaling.
Wang Y; Wang R; Wang Y; Peng R; Wu Y; Yuan Y
Drug Des Devel Ther; 2015; 9():6303-17. PubMed ID: 26664050
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of octreotide on the progression of hepatic fibrosis via the regulation of Bcl-2/Bax and PI3K/AKT signaling pathways.
Zhang C; An R; Bao YW; Meng XM; Wang TQ; Sun HN; Pan FM; Zhang C
Int Immunopharmacol; 2019 Aug; 73():515-526. PubMed ID: 31173973
[TBL] [Abstract][Full Text] [Related]
4. Pien-Tze-Huang ameliorates hepatic fibrosis via suppressing NF-κB pathway and promoting HSC apoptosis.
Zheng H; Wang X; Zhang Y; Chen L; Hua L; Xu W
J Ethnopharmacol; 2019 Nov; 244():111856. PubMed ID: 30959141
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of salvianolic acid B on CCl(4)-induced hepatic fibrosis through regulating NF-κB/IκBα signaling.
Wang R; Yu XY; Guo ZY; Wang YJ; Wu Y; Yuan YF
J Ethnopharmacol; 2012 Dec; 144(3):592-8. PubMed ID: 23041223
[TBL] [Abstract][Full Text] [Related]
6. Trolline Ameliorates Liver Fibrosis by Inhibiting the NF-κB Pathway, Promoting HSC Apoptosis and Suppressing Autophagy.
Bai F; Huang Q; Nie J; Lu S; Lu C; Zhu X; Wang Y; Zhuo L; Lu Z; Lin X
Cell Physiol Biochem; 2017; 44(2):436-446. PubMed ID: 29141243
[TBL] [Abstract][Full Text] [Related]
7. Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis.
França MER; Rocha SWS; Oliveira WH; Santos LA; de Oliveira AGV; Barbosa KPS; Nunes AKS; Rodrigues GB; Lós DB; Peixoto CA
Inflammopharmacology; 2018 Apr; 26(2):599-609. PubMed ID: 28409388
[TBL] [Abstract][Full Text] [Related]
8. Hepatoprotective effects of zingerone on carbon tetrachloride- and dimethylnitrosamine-induced liver injuries in rats.
Cheong KO; Shin DS; Bak J; Lee C; Kim KW; Je NK; Chung HY; Yoon S; Moon JO
Arch Pharm Res; 2016 Feb; 39(2):279-291. PubMed ID: 26667466
[TBL] [Abstract][Full Text] [Related]
9. Plumbagin ameliorates liver fibrosis via a ROS-mediated NF-кB signaling pathway in vitro and in vivo.
Chen Y; Zhao C; Liu X; Wu G; Zhong J; Zhao T; Li J; Lin Y; Zhou Y; Wei Y
Biomed Pharmacother; 2019 Aug; 116():108923. PubMed ID: 31154269
[TBL] [Abstract][Full Text] [Related]
10. Anti-fibrotic effects of specific-siRNA targeting of the receptor for advanced glycation end products in a rat model of experimental hepatic fibrosis.
Cai XG; Xia JR; Li WD; Lu FL; Liu J; Lu Q; Zhi H
Mol Med Rep; 2014 Jul; 10(1):306-14. PubMed ID: 24804792
[TBL] [Abstract][Full Text] [Related]
11. Tanshinol ameliorates CCl
Wang R; Wang J; Song F; Li S; Yuan Y
Drug Des Devel Ther; 2018; 12():1281-1292. PubMed ID: 29844659
[TBL] [Abstract][Full Text] [Related]
12. Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats.
He J; Bai K; Hong B; Zhang F; Zheng S
Int Immunopharmacol; 2017 Dec; 53():56-62. PubMed ID: 29035816
[TBL] [Abstract][Full Text] [Related]
13. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
[TBL] [Abstract][Full Text] [Related]
14. Hepatoprotective effect of total flavonoids of Mallotus apelta (Lour.) Muell.Arg. leaf against carbon tetrachloride-induced liver fibrosis in rats via modulation of TGF-β1/Smad and NF-κB signaling pathways.
Zhang B; Lai L; Tan Y; Liang Q; Bai F; Mai W; Huang Q; Ye Y
J Ethnopharmacol; 2020 May; 254():112714. PubMed ID: 32105750
[TBL] [Abstract][Full Text] [Related]
15. Octreotide attenuates hepatic fibrosis and hepatic stellate cells proliferation and activation by inhibiting Wnt/β-catenin signaling pathway, c-Myc and cyclin D1.
Zhang C; Liu XQ; Sun HN; Meng XM; Bao YW; Zhang HP; Pan FM; Zhang C
Int Immunopharmacol; 2018 Oct; 63():183-190. PubMed ID: 30098497
[TBL] [Abstract][Full Text] [Related]
16. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
17. Quercetin attenuates the activation of hepatic stellate cells and liver fibrosis in mice through modulation of HMGB1-TLR2/4-NF-κB signaling pathways.
Li X; Jin Q; Yao Q; Xu B; Li Z; Tu C
Toxicol Lett; 2016 Nov; 261():1-12. PubMed ID: 27601294
[TBL] [Abstract][Full Text] [Related]
18. Quercetin protects mouse liver against CCl₄-induced inflammation by the TLR2/4 and MAPK/NF-κB pathway.
Ma JQ; Li Z; Xie WR; Liu CM; Liu SS
Int Immunopharmacol; 2015 Sep; 28(1):531-9. PubMed ID: 26218279
[TBL] [Abstract][Full Text] [Related]
19. Antifibrotic effects of Fraxetin on carbon tetrachloride-induced liver fibrosis by targeting NF-κB/IκBα, MAPKs and Bcl-2/Bax pathways.
Wu B; Wang R; Li S; Wang Y; Song F; Gu Y; Yuan Y
Pharmacol Rep; 2019 Jun; 71(3):409-416. PubMed ID: 31003150
[TBL] [Abstract][Full Text] [Related]
20. Oligonol Ameliorates CCl₄-Induced Liver Injury in Rats via the NF-Kappa B and MAPK Signaling Pathways.
Bak J; Je NK; Chung HY; Yokozawa T; Yoon S; Moon JO
Oxid Med Cell Longev; 2016; 2016():3935841. PubMed ID: 26798422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
